(Q34264308)

1 August 2017

1 reference

title

Utility of flow cytometric analysis of mast cells in the diagnosis and classification of adult mastocytosis (English)

1 reference

1 August 2017

0 references

1 reference

Escribano L

1

1 reference

1 August 2017

Díaz-Agustín B

2

1 reference

1 August 2017

Bellas C

3

1 reference

1 August 2017

Navalón R

4

1 reference

1 August 2017

Nuñez R

5

1 reference

1 August 2017

Sperr WR

6

1 reference

1 August 2017

Schernthaner GH

7

1 reference

1 August 2017

Valent P

8

1 reference

1 August 2017

Orfao A

9

1 reference

1 August 2017

1 July 2001

1 reference

1 August 2017

1 reference

1 August 2017

25

1 reference

1 August 2017

7

1 reference

1 August 2017

563-570

1 reference

Tissue mast cells in health and disease.

1 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Mast cells and mast cell neoplasia: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Systemic mastocytosis. Extracutaneous manifestations.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Bone marrow findings in systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Systemic mastocytosis: retrospective review of a decade's clinical experience at the Brigham and Women's Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Cutaneous mastocytosis in adults. evaluation of 14 patients with respect to systemic disease manifestations

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Urticaria pigmentosa: a clinical, hematopathologic, and serologic study of 30 adults

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Systemic mast cell disease: a clinical and hematopathologic study of 26 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Morphologic properties of neoplastic mast cells: delineation of stages of maturation and implication for cytological grading of mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Development of a new, more sensitive immunoassay for human tryptase: use in systemic anaphylaxis.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

The alpha form of human tryptase is the predominant type present in blood at baseline in normal subjects and is elevated in those with systemic mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Markers of mast cell degranulation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

The potential clinical utility of serum alpha-protryptase levels

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Diagnostic value of immunostaining for tryptase in patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

The phenotype of human eosinophils, basophils, and mast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Phenotypic characterization of human skin mast cells by combined staining with toluidine blue and CD antibodies.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Expression of homing receptors and related molecules on human mast cells and basophils: a comparative analysis using multi-color flow cytometry and toluidine blue/immunofluorescence staining techniques.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Expression of lymphoid-associated antigens in mast cells: report of a case of systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Sequential immunophenotypic analysis of mast cells in a case of systemic mast cell disease evolving to a mast cell leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Immunophenotype of bone marrow mast cells in indolent systemic mast cell disease in adults

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Immunophenotypic characterization of human bone marrow mast cells. A flow cytometric study of normal and pathological bone marrow samples.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Further characterization of surface membrane structures expressed on human basophils and mast cells.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Human bone marrow mast cells from indolent systemic mast cell disease constitutively express increased amounts of the CD63 protein on their surface

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

The CD69 early activation molecule is overexpressed in human bone marrow mast cells from adults with indolent systemic mast cell disease

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Variable expression of activation-linked surface antigens on human mast cells in health and disease

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Expression of Bcl-2 by human bone marrow mast cells and its overexpression in mast cell leukemia.

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Lymphoid cells and tissue mast cells of bone marrow lesions in systemic mastocytosis: a histological and immunohistological study

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Comparative immunophenotypic analysis of human mast cells, blood basophils and monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Human cell-adhesion molecule CD2 binds CD58 (LFA-3) with a very low affinity and an extremely fast dissociation rate but does not bind CD48 or CD59

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Overlapping but nonidentical binding sites on CD2 for CD58 and a second ligand CD59

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

The biology of stem cell factor and its receptor C-kit

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Adhesion of mouse mast cells to fibroblasts: adverse effects of steel (Sl) mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Cytokines increase human hemopoietic cell adhesiveness by activation of very late antigen (VLA)-4 and VLA-5 integrins

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Elevated expression of the proto-oncogene c-kit in patients with mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0145-2126%2801%2900050-9

7 January 2021

10.1016/S0145-2126(01)00050-9

Identifiers

DOI

1 reference

1 August 2017

1 reference